Annual Long Term Debt
$11.19 M
+$2.85 M+34.18%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual long term debt is $11.19 million, with the most recent change of +$2.85 million (+34.18%) on December 31, 2023.
- During the last 3 years, BRNS annual long term debt has fallen by -$34.98 million (-75.76%).
- BRNS annual long term debt is now -75.76% below its all-time high of $46.17 million, reached on December 1, 2020.
Performance
BRNS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$10.68 M
+$29.00 K+0.27%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly long term debt is $10.68 million, with the most recent change of +$29.00 thousand (+0.27%) on September 30, 2024.
- Over the past year, BRNS quarterly long term debt has stayed the same.
- BRNS quarterly long term debt is now -76.86% below its all-time high of $46.17 million, reached on December 1, 2020.
Performance
BRNS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
BRNS Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.2% | 0.0% |
| 3 y3 years | -75.8% | +28.1% |
| 5 y5 years | +596.9% | +671.9% |
BRNS Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.1% | -4.6% | +66.8% |
| 5 y | 5-year | -75.8% | +596.9% | -76.9% | +671.9% |
| alltime | all time | -75.8% | +596.9% | -76.9% | +671.9% |
Barinthus Biotherapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.68 M(+0.3%) |
| Jun 2024 | - | $10.65 M(-2.2%) |
| Mar 2024 | - | $10.90 M(-2.6%) |
| Dec 2023 | $11.19 M(+34.2%) | $11.19 M(-0.1%) |
| Sep 2023 | - | $11.20 M(+1.4%) |
| Jun 2023 | - | $11.04 M(+10.4%) |
| Mar 2023 | - | $10.01 M(+20.0%) |
| Dec 2022 | $8.34 M | $8.34 M(+3.3%) |
| Sep 2022 | - | $8.07 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $8.31 M(+29.8%) |
| Mar 2022 | - | $6.40 M(-2.1%) |
| Dec 2021 | $6.54 M(-85.8%) | - |
| Dec 2021 | - | $6.54 M(-15.4%) |
| Sep 2021 | - | $7.73 M(+458.4%) |
| Jun 2021 | - | $1.38 M(-3.6%) |
| Mar 2021 | - | $1.44 M(-96.9%) |
| Dec 2020 | $46.17 M(+2775.3%) | $46.17 M |
| Dec 2019 | $1.61 M | - |
FAQ
- What is Barinthus Biotherapeutics annual long term debt?
- What is the all time high annual long term debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual long term debt year-on-year change?
- What is Barinthus Biotherapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly long term debt year-on-year change?
What is Barinthus Biotherapeutics annual long term debt?
The current annual long term debt of BRNS is $11.19 M
What is the all time high annual long term debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual long term debt is $46.17 M
What is Barinthus Biotherapeutics annual long term debt year-on-year change?
Over the past year, BRNS annual long term debt has changed by +$2.85 M (+34.18%)
What is Barinthus Biotherapeutics quarterly long term debt?
The current quarterly long term debt of BRNS is $10.68 M
What is the all time high quarterly long term debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly long term debt is $46.17 M
What is Barinthus Biotherapeutics quarterly long term debt year-on-year change?
Over the past year, BRNS quarterly long term debt has changed by $0.00 (0.00%)